Insider Trading Alert - OPK, PSMT And LTM Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, April 16, 2014, 80 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $35.35 to $75,000,000.00.

Highlighted Stocks Traded by Insiders:

Opko Health (OPK) - FREE Research Report

Frost Phillip Md Et Al who is CEO & Chairman at Opko Health bought 129,800 shares at $8.04 on April 16, 2014. Following this transaction, the CEO & Chairman owned 140.2 million shares meaning that the stake was reduced by 0.09% with the 129,800-share transaction.

The shares most recently traded at $8.27, up $0.23, or 2.78% since the insider transaction. Historical insider transactions for Opko Health go as follows:

  • 4-Week # shares bought: 10,000
  • 4-Week # shares sold: 46,730
  • 12-Week # shares bought: 30,000
  • 12-Week # shares sold: 46,730
  • 24-Week # shares bought: 40,000
  • 24-Week # shares sold: 46,730

The average volume for Opko Health has been 3.1 million shares per day over the past 30 days. Opko Health has a market cap of $3.4 billion and is part of the health care sector and health services industry. Shares are down 1.3% year-to-date as of the close of trading on Wednesday.

Opko Health, Inc., a biopharmaceutical and diagnostics company, is engaged in the discovery, development, and commercialization of novel and proprietary technologies. It operates in two segments, Pharmaceuticals and Diagnostics. Currently there are 4 analysts that rate Opko Health a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on OPK - FREE

TheStreet Quant Ratings rates Opko Health as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, deteriorating net income and weak operating cash flow. Get the full Opko Health Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Pricesmart (PSMT) - FREE Research Report

Laparte Jose Luis who is Ceo And President at Pricesmart sold 16,976 shares at $94.60 on April 16, 2014. Following this transaction, the Ceo And President owned 195,257 shares meaning that the stake was reduced by 8% with the 16,976-share transaction.

The shares most recently traded at $93.21, down $1.39, or 1.49% since the insider transaction. Historical insider transactions for Pricesmart go as follows:

  • 4-Week # shares sold: 2,000
  • 12-Week # shares sold: 9,006
  • 24-Week # shares sold: 16,064

The average volume for Pricesmart has been 170,600 shares per day over the past 30 days. Pricesmart has a market cap of $2.8 billion and is part of the services sector and retail industry. Shares are down 20.02% year-to-date as of the close of trading on Wednesday.

PriceSmart, Inc., together with its subsidiaries, owns and operates membership shopping warehouse clubs in Latin American and Caribbean. The stock currently has a dividend yield of 0.64%. The company has a P/E ratio of 38.9. Currently there is 1 analyst that rates Pricesmart a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PSMT - FREE

TheStreet Quant Ratings rates Pricesmart as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, increase in net income, notable return on equity and good cash flow from operations. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full Pricesmart Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Life Time Fitness (LTM) - FREE Research Report

Zwiefel Jeffrey G who is Executive Vice President at Life Time Fitness sold 15,000 shares at $50.00 on April 16, 2014. Following this transaction, the Executive Vice President owned 29,406 shares meaning that the stake was reduced by 33.78% with the 15,000-share transaction.

The shares most recently traded at $50.01, up $0.01, or 0.02% since the insider transaction. Historical insider transactions for Life Time Fitness go as follows:

  • 4-Week # shares bought: 2,000
  • 4-Week # shares sold: 1,475
  • 12-Week # shares bought: 2,000
  • 12-Week # shares sold: 10,520
  • 24-Week # shares bought: 2,000
  • 24-Week # shares sold: 10,520

The average volume for Life Time Fitness has been 654,600 shares per day over the past 30 days. Life Time Fitness has a market cap of $2.2 billion and is part of the services sector and leisure industry. Shares are up 7.55% year-to-date as of the close of trading on Wednesday.

Life Time Fitness, Inc. designs, builds, and operates sports and athletic, professional fitness, family recreation, and spa centers. The company has a P/E ratio of 16.6. Currently there are 7 analysts that rate Life Time Fitness a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on LTM - FREE

TheStreet Quant Ratings rates Life Time Fitness as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in stock price during the past year, growth in earnings per share, reasonable valuation levels and good cash flow from operations. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Life Time Fitness Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Lowe's Snags Ex-Home Depot Exec as CEO; ISPs Face Competitive Threat -- ICYMI

Lowe's Snags Ex-Home Depot Exec as CEO; ISPs Face Competitive Threat -- ICYMI

Dow Slips 178 Points; S&P 500 and Nasdaq Also Decline

Dow Slips 178 Points; S&P 500 and Nasdaq Also Decline

Legal Weed Sales in California Are Off to a Less Than Smokin' Start

Legal Weed Sales in California Are Off to a Less Than Smokin' Start

Owner of Moviepass Sees Stock Plummet

Owner of Moviepass Sees Stock Plummet

Ford, GM Gain as China Slashes Auto Import Tariffs

Ford, GM Gain as China Slashes Auto Import Tariffs